SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
- Wafaa B. Alsoussi
- , Sameer Kumar Malladi
- , Julian Q. Zhou
- , Zhuoming Liu
- , Baoling Ying
- , Wooseob Kim
- , Aaron J. Schmitz
- , Tingting Lei
- , Stephen C. Horvath
- , Alexandria J. Sturtz
- , Katherine M. McIntire
- , Birk Evavold
- , Fangjie Han
- , Suzanne M. Scheaffer
- , Isabella F. Fox
- , Senaa F. Mirza
- , Luis Parra-Rodriguez
- , Raffael Nachbagauer
- , Biliana Nestorova
- , Spyros Chalkias
- Department of Molecular Microbiology
- Division of Laboratory and Genomic Medicine
- Institute of Clinical and Translational Sciences (ICTS)
- COVID-19 Researchers
- Division of Infectious Diseases
- Siteman Cancer Center
- Section of Abdominal Imaging
- School of Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- Bursky Center for Human Immunology and Immunotherapy
- Rheumatic Diseases Research Resource-Based Center
- Division of Immunobiology
- Brain Tumor Center
- Section of Hematological Malignancies
- Center of Regenerative Medicine
Research output: Contribution to journal › Article › peer-review
108
Link opens in a new tab
Scopus
citations